ANKFY1
Basic information
Region (hg38): 17:4163821-4263995
Links
Phenotypes
GenCC
Source:
- familial idiopathic steroid-resistant nephrotic syndrome (Supportive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANKFY1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 23 | ||||
missense | 64 | 70 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 29 | 34 | ||||
Total | 0 | 0 | 64 | 28 | 35 |
Variants in ANKFY1
This is a list of pathogenic ClinVar variants found in the ANKFY1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-4167769-G-A | ANKFY1-related disorder | Likely benign (Jun 18, 2020) | ||
17-4167820-T-C | not specified | Uncertain significance (Nov 20, 2023) | ||
17-4167856-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
17-4167894-A-C | not specified | Uncertain significance (Feb 22, 2024) | ||
17-4167951-C-T | Benign (May 10, 2021) | |||
17-4168008-G-C | Benign (May 10, 2021) | |||
17-4168032-C-G | Benign (May 10, 2021) | |||
17-4169247-A-C | not specified | Uncertain significance (Mar 18, 2024) | ||
17-4169261-C-G | not specified | Uncertain significance (Jan 31, 2023) | ||
17-4169280-A-G | not specified | Uncertain significance (Mar 13, 2023) | ||
17-4169413-G-A | Benign (May 11, 2021) | |||
17-4169467-G-C | Benign (May 11, 2021) | |||
17-4170784-T-C | not specified | Uncertain significance (May 11, 2022) | ||
17-4170817-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
17-4170830-G-A | ANKFY1-related disorder | Likely benign (May 21, 2021) | ||
17-4170870-C-A | ANKFY1-related disorder | Likely benign (Jun 23, 2020) | ||
17-4170967-A-C | Benign (May 10, 2021) | |||
17-4172571-C-T | not specified | Uncertain significance (May 17, 2023) | ||
17-4172624-A-G | not specified | Uncertain significance (Dec 22, 2023) | ||
17-4172670-G-C | not specified | Uncertain significance (Jan 10, 2023) | ||
17-4172671-T-G | ANKFY1-related disorder | Likely benign (Aug 08, 2019) | ||
17-4173320-C-T | Benign (May 11, 2021) | |||
17-4173371-G-A | ANKFY1-related disorder | Likely benign (Jun 04, 2019) | ||
17-4173371-G-C | ANKFY1-related disorder | Likely benign (Apr 26, 2021) | ||
17-4173374-G-A | Benign (Apr 25, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANKFY1 | protein_coding | protein_coding | ENST00000570535 | 25 | 100074 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.956 | 0.0437 | 124792 | 0 | 22 | 124814 | 0.0000881 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.46 | 531 | 717 | 0.741 | 0.0000425 | 7906 |
Missense in Polyphen | 157 | 270.48 | 0.58046 | 3015 | ||
Synonymous | 1.02 | 283 | 306 | 0.926 | 0.0000204 | 2431 |
Loss of Function | 5.74 | 11 | 58.3 | 0.189 | 0.00000316 | 653 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000241 | 0.000241 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.0000800 | 0.0000794 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.0000686 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Proposed effector of Rab5. Binds to phosphatidylinositol 3-phosphate (PI(3)P). Involved in homotypic early endosome fusion and to a lesser extent in heterotypic fusion of chlathrin-coated vesicles with early endosomes. Involved in macropinocytosis; the function is dependent on Rab5-GTP. Required for correct endosomal localization. Involved in the internalization and trafficking of activated tyrosine kinase receptors such as PDGFRB. Regulates the subcellular localization of the retromer complex in a EHD1- dependent manner. Involved in endosome-to-Golgi transport and biosynthetic transport to late endosomes and lysosomes indicative for a regulation of retromer complex-mediated retrograde transport. {ECO:0000269|PubMed:15328530, ECO:0000269|PubMed:22284051, ECO:0000269|PubMed:24102721}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 0.491
- rvis_EVS
- -1.75
- rvis_percentile_EVS
- 2.36
Haploinsufficiency Scores
- pHI
- 0.0827
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.654
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.926
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ankfy1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- endocytosis;endosomal transport;endosomal vesicle fusion;retrograde transport, endosome to Golgi;positive regulation of pinocytosis;Golgi to lysosome transport
- Cellular component
- lysosomal membrane;endosome;early endosome;cytosol;endosome membrane;membrane;retromer complex;intracellular membrane-bounded organelle;macropinosome;extracellular exosome
- Molecular function
- protein binding;Rab GTPase binding;metal ion binding;phosphatidylinositol phosphate binding